expense for sales staff, cost of advertisement media for product promotion, compensation paid to Zuellig Pharma Ltd. under the Distribution Agreement and compensation for distribution of the Company’s
agreement 312.0 1.9 0.6 0.0 (311.4) (99.8) Gain on disposals of investments in subsidiaries 314.8 1.9 458.6 3.2 143.7 45.7 Other income 262.0 1.6 465.3 3.3 203.3 77.6 Total Revenues 16,637.8 100.0 14,122.1
result of repayment of long-term loans from financial institutions, and increase in liability under hire purchase agreement amount of Baht 3.41 million. 3. Shareholder equity as at June 30, 2017 amount of
hire purchase agreement amount of Baht 4.07 million. 3. Shareholder equity as at September 30, 2017 amount of Baht 648.33 million decrease from December 31, 2016 by Baht 30.08 or 4.43% , since the
attendance in the year and business operation of the Company and its subsidiary as follows; 1. Significant changes during the year Wiik & Hoeglund Public Company Limited (WIIK) Principally engaged in the
Clause 2, the derivatives dealer shall ensure efficient prevention of conflicts of interest and access to inside information between operational unit and personnel, risk management in business operation
derivatives dealer shall ensure efficient prevention of conflicts of interest and access to inside information between operational unit and personnel, risk management in business operation, operational
for sale of the investment units of a mutual fund or in an agreement for private fund management, as the case may be; (4) the evidentiary documentation supplementing the consideration for investing in